Professional Summary
Professional Overview
Bruno Viviani is the Co-Founder of CBfarma, a dynamic startup in the pharmaceutical industry. With a strong background in sales and project management, he brings a wealth of expertise in driving business growth and operational efficiency.
Experience Summary
Current Role
As the Co-Founder of CBfarma, Bruno is responsible for overseeing the company's strategic direction, resource allocation, and cross-functional team coordination. He has played a pivotal role in establishing the company's presence in the local market, securing key partnerships, and driving the development of innovative pharmaceutical solutions.
Career Progression
Prior to co-founding CBfarma, Bruno held various sales and project management roles at WEG, a leading global manufacturer of electrical equipment. During his tenure, he honed his skills in client relationship management, sales strategy, and project implementation, contributing to the company's success and growth.
Academic Background
Bruno holds a Bachelor's degree in Business Administration from a reputable university in Brazil, where he graduated with distinction.
Areas of Expertise
- Sales and business development
- Project management and operational optimization
- Strategic planning and decision-making
- Stakeholder management and cross-functional collaboration
- Product innovation and market analysis
Professional Impact
Throughout his career, Bruno has demonstrated a strong track record of driving measurable business results. At WEG, he consistently exceeded sales targets and successfully implemented complex projects, earning him recognition as a top-performing employee. As the Co-Founder of CBfarma, he has leveraged his expertise to establish the company as a promising player in the pharmaceutical industry, securing key partnerships and spearheading the development of innovative products.
Conclusion
With his extensive experience, strategic mindset, and proven track record of success, Bruno Viviani is well-positioned to continue driving the growth and success of CBfarma. His dedication to innovation, operational excellence, and collaborative leadership make him a valuable asset in the pharmaceutical industry.
